[Comments on the Ito et al. article (Endocr J. 2008 Oct 8. Epub ahead of print)] The lack of clinicopathological correlation of BRAF mutation in papillary thyroid cancer needs to be interpreted with caution.
Xing
Mingzhao
M
D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000235:genetics* / Q000601:surgery; D018572:Disease-Free Survival; D006801:Humans; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000601:surgery
C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf